Last reviewed · How we verify

NCT05004207

Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.

Status unknown Last updated 13 August 2021
What this trial tests

trial testing 99mTc Scintigraphy in Small Bowel Disease in 50 participants. Status unknown.

Timeline
1 July 2021
Primary endpoint
31 January 2022
31 January 2022

Quick facts

Lead sponsorAsian Institute of Gastroenterology, India
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date1 July 2021
Primary completion31 January 2022
Estimated completion31 January 2022
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Asian Institute of Gastroenterology, India

Who can join

18 and older, any sex, with Small Bowel Disease or Motility Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radionuclide scintigraphy is the gold standard technique to interpret OCTT but there is no normative data available for its interpretation in Indian population. Previous studies to determine OCTT have all been done with LHBT, which has many limitations. Besides there are few small comparative studies between scintigraphy and LHBT, that too not in Indian population. The aim of this study is to validate LHBT to measure OCTT compared with scintigraphy and to standardize the normal OCTT in healthy individuals

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Small Bowel Disease

Currently open trials in the same condition.

Other Asian Institute of Gastroenterology, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05004207.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing